Galectin Therapeutics Names Shlevin COO
Galectin Therapeutics Inc. (NASDAQ: GALT) today announced the appointment of Dr. Harold H. Shlevin as Chief Operating Officer. Dr. Shlevin succeeds, as of October 1, 2012, Maureen Foley who helped found the Company and served as its COO since its inception and as its corporate secretary. Dr. Shlevin is a bioscience industry executive with 25 years of senior management experience in the development and commercialization of pharmaceuticals, diagnostics and vaccines.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.